Precision-targeting of pathogens using bacteriophage and antimicrobial peptides

BBSRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

September 29, 2027
Response Due
Active
Status

Opportunity Overview

Salmonellosis is a major food-borne pathogen worldwide, frequently associated with contaminated poultry and eggs. Salmonella Infantis (SI) is the 4th most common serotype in human infections in the EU, and the most frequent serotype in broiler chickens. Worryingly, multidrug-resistant isolates are increasingly common in Europe, particularly those which have acquired a pESI megaplasmid encoding resistance to multiple classes of antibiotics as well as virulence genes and enhanced tolerance of heavy metals and biocides. Alternative approaches to controlling antimicrobial resistance in Salmonella and other pathogens are urgently needed.
Two such approaches are biological control using viruses which specifically target bacteria (bacteriophages) and antimicrobial peptides (AMPs). Both approaches have unique advantages over antibiotics. Bacteriophage are self-replicating and self-limiting - reproducing only when susceptible bacteria are present. Unlike broad-spectrum antibiotics, they target a specific genus, species or strain of bacterium, avoiding potentially harmful dysbiosis in the patient.
AMPs form the basis of effective innate immune responses to bacteria and other micro-organisms in all classes of life. The most common mode of action of these to bacterial cells is thought to be via a destabilisation of the bacterial cell membrane resulting in cell lysis. AMPs can vary in size from less than 10aas to 60-70aas, their small size enabling rapid diffusion, and penetration/destabilisation of bacterial biofilms.
In this project we aim to combine the strengths of both approaches to control SI, with the ultimate aim of using this combination therapy in poultry, and potentially as a model for use in human medicine.
The PhD study is divided into two strands:
1. Isolation and characterisation of antimicrobial peptides (AMPs) specifically targeting SI.
Next Generation Peptide Phage Display (NGPD) will be used to isolate or modify peptides specifically targeting the surface of...

This is one of 2,051 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyBBSRC
CountryUnited Kingdom
CategoryResearch Development
PublishedSeptember 30, 2023
Procurement stageActive solicitation
Response dueSeptember 29, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedSeptember 21, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

PAML 5: A friendly and powerful bioinformatics resource for phylogenomics
Something in the air - investigating the impact of air pollution on neurodevelopment in the zebrafish model.
Structural bioinformatics and chemogenomics approaches to navigate GPCR ligand interaction space
Assessing the threat of antimicrobial resistance: A framework to support decision-making to ensure resilient aquaculture supplies
Developmental mechanisms of air space morphogenesis in plant leaves
Modulation of a neuromodulator: Insulin sensing in the basal forebrain
Novel multi excitation Raman ME Raman technologies for clinical identification of respiratory biofilms in ventilator associated pneumonia VAP
Does functional misfolding of TonB drive import across the outer membrane of Gram negative bacteria?

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.